Literature DB >> 16553817

Differential utilization by Haemophilus influenzae of haemoglobin complexed to the three human haptoglobin phenotypes.

Daniel J Morton1, Timothy M VanWagoner, Thomas W Seale, Paul W Whitby, Terrence L Stull.   

Abstract

Haemophilus influenzae has an absolute requirement for heme, which may be supplied as the haemoglobin-haptoglobin complex. Utilization of haemoglobin-haptoglobin by H. influenzae is mediated by a family of proteins termed the haemoglobin-haptoglobin binding proteins (Hgps), of which a given strain may contain up to four genes. Human haptoglobin occurs in three phenotypes (1-1, 2-1 and 2-2). Using mutant derivatives of an H. influenzae type b strain that expressed single Hgps we analysed the ability of each Hgp to utilize haemoglobin complexed to the various haptoglobin phenotypes. A strain expressing only HgpB was able to utilize haemoglobin bound to all haptoglobin phenotypes significantly better than strains expressing either HgpA or HgpC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553817     DOI: 10.1111/j.1574-695X.2006.00052.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  10 in total

Review 1.  Heme Synthesis and Acquisition in Bacterial Pathogens.

Authors:  Jacob E Choby; Eric P Skaar
Journal:  J Mol Biol       Date:  2016-03-24       Impact factor: 5.469

2.  Complex role of hemoglobin and hemoglobin-haptoglobin binding proteins in Haemophilus influenzae virulence in the infant rat model of invasive infection.

Authors:  Thomas W Seale; Daniel J Morton; Paul W Whitby; Roman Wolf; Stanley D Kosanke; Timothy M VanWagoner; Terrence L Stull
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

3.  Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae.

Authors:  Daniel J Morton; Elizabeth J Turman; Patrick D Hensley; Timothy M VanWagoner; Thomas W Seale; Paul W Whitby; Terrence L Stull
Journal:  BMC Microbiol       Date:  2010-04-15       Impact factor: 3.605

4.  The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinant.

Authors:  Daniel J Morton; Thomas W Seale; Lauren O Bakaletz; Joseph A Jurcisek; Ann Smith; Timothy M VanWagoner; Paul W Whitby; Terrence L Stull
Journal:  Int J Med Microbiol       Date:  2009-05-17       Impact factor: 3.473

5.  Signature-tagging of a bacterial isolate demonstrates phenotypic variability of the progeny in vivo in the absence of defined mutations.

Authors:  Paul W Whitby; Timothy M VanWagoner; Daniel J Morton; Thomas W Seale; Jennifer M Springer; Randy J Hempel; Terrence L Stull
Journal:  J Microbiol Methods       Date:  2012-10-22       Impact factor: 2.363

6.  A functional tonB gene is required for both virulence and competitive fitness in a chinchilla model of Haemophilus influenzae otitis media.

Authors:  Daniel J Morton; Randy J Hempel; Thomas W Seale; Paul W Whitby; Terrence L Stull
Journal:  BMC Res Notes       Date:  2012-06-25

7.  The dppBCDF gene cluster of Haemophilus influenzae: Role in heme utilization.

Authors:  Daniel J Morton; Thomas W Seale; Timothy M Vanwagoner; Paul W Whitby; Terrence L Stull
Journal:  BMC Res Notes       Date:  2009-08-24

8.  The role of the RNA chaperone Hfq in Haemophilus influenzae pathogenesis.

Authors:  Randy J Hempel; Daniel J Morton; Thomas W Seale; Paul W Whitby; Terrence L Stull
Journal:  BMC Microbiol       Date:  2013-06-16       Impact factor: 3.605

9.  Haemophilus influenzae OxyR: characterization of its regulation, regulon and role in fitness.

Authors:  Paul W Whitby; Daniel J Morton; Timothy M Vanwagoner; Thomas W Seale; Brett K Cole; Huda J Mussa; Phillip A McGhee; Chee Yoon S Bauer; Jennifer M Springer; Terrence L Stull
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  How Severe Anaemia Might Influence the Risk of Invasive Bacterial Infections in African Children.

Authors:  Kelvin M Abuga; John Muthii Muriuki; Thomas N Williams; Sarah H Atkinson
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.